Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FFFNX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,916
Award facts
- Contract value 100% obligated
- $20,915.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Cosentyx Unoready 300 mg pen injections in 2 mL formulations, with a ceiling value of $20,915.52. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 17, 2025. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999,999,999.00 pharmaceutical supply vehicle running through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. As a prime contractor on the DLA Troop Support Medical IDC, the company supplies a broad portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Cosentyx (secukinumab) is a biologic immunosuppressant used to treat autoimmune and inflammatory conditions, making this delivery essential for supporting the pharmaceutical needs of the federal military and healthcare infrastructure.
Quick answers
Who was awarded contract SPE2DB26FFFNX?
SPE2DB26FFFNX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 16, 2025.
How much is contract SPE2DB26FFFNX worth?
The government has obligated $20,916 on SPE2DB26FFFNX.
Is contract SPE2DB26FFFNX an order under another contract?
Yes. SPE2DB26FFFNX is a delivery order under SPE2DB24D3013, an indefinite delivery contract.
Was contract SPE2DB26FFFNX competed?
The extent of competition for SPE2DB26FFFNX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award